Metabolic effects of breastfeeding in women with previous gestational diabetes diagnosed according to the IADPSG criteria.


Journal

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
ISSN: 1476-4954
Titre abrégé: J Matern Fetal Neonatal Med
Pays: England
ID NLM: 101136916

Informations de publication

Date de publication:
Jan 2019
Historique:
pubmed: 8 9 2017
medline: 15 2 2019
entrez: 8 9 2017
Statut: ppublish

Résumé

Some studies have already investigated about the short-term favorable metabolic effects of breastfeeding in women with previous gestational diabetes mellitus (GDM). The aim of our study is to confirm whether the positive effects reported are maintained in the larger cohorts of patients with mild form of gestational diabetes mellitus (GDM) because recently diagnosed according to IADPSG criteria. This retrospective study includes 97 evaluable consecutive women with prior GDM who have the follow-up oral glucose tolerance test at least 3 months after delivery. Fasting and 2-h plasma glucose values, homeostasis model assessment (HOMA-IR), total cholesterol, and triglycerides were obtained in pregnancy and during the post-partum control. These patients were divided in 81 (83.5%) who lactate until 3 months and 16 (16.5%) who did not lactate. During pregnancy, there are no significant differences between the two groups for age, BMI, fasting and 2-h plasma glucose values, HOMA-IR, total cholesterol and triglycerides. At the postpartum control, we have at univariate analysis significant differences for all these parameters except total cholesterol. After adjustment for confounders we still have, in the breastfeeding group, HOMA-IR reduction (OR 0.370; 95% CI 0.170-0.805; p < .01) as significant independent variable, whose improvement is the most acknowledged important factor for the prevention of abnormal glucose tolerance later in life. These encouraging results confirm our determination to warmly advice the women affected by GDM to breastfeeding at least for 3 months.

Sections du résumé

BACKGROUND BACKGROUND
Some studies have already investigated about the short-term favorable metabolic effects of breastfeeding in women with previous gestational diabetes mellitus (GDM).
AIM OBJECTIVE
The aim of our study is to confirm whether the positive effects reported are maintained in the larger cohorts of patients with mild form of gestational diabetes mellitus (GDM) because recently diagnosed according to IADPSG criteria.
MATERIALS AND METHODS METHODS
This retrospective study includes 97 evaluable consecutive women with prior GDM who have the follow-up oral glucose tolerance test at least 3 months after delivery. Fasting and 2-h plasma glucose values, homeostasis model assessment (HOMA-IR), total cholesterol, and triglycerides were obtained in pregnancy and during the post-partum control.
RESULTS RESULTS
These patients were divided in 81 (83.5%) who lactate until 3 months and 16 (16.5%) who did not lactate. During pregnancy, there are no significant differences between the two groups for age, BMI, fasting and 2-h plasma glucose values, HOMA-IR, total cholesterol and triglycerides. At the postpartum control, we have at univariate analysis significant differences for all these parameters except total cholesterol. After adjustment for confounders we still have, in the breastfeeding group, HOMA-IR reduction (OR 0.370; 95% CI 0.170-0.805; p < .01) as significant independent variable, whose improvement is the most acknowledged important factor for the prevention of abnormal glucose tolerance later in life.
CONCLUSION CONCLUSIONS
These encouraging results confirm our determination to warmly advice the women affected by GDM to breastfeeding at least for 3 months.

Identifiants

pubmed: 28877616
doi: 10.1080/14767058.2017.1377175
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

225-228

Auteurs

Francesco Corrado (F)

a Dipartimento di Patologia Umana dell'Adulto e dell'Età Evolutiva "G. Barresi" , Università degli Studi di Messina , Messina , Italy.

Loretta Giunta (L)

b Dipartimento di Medicina Clinica e Sperimentale , Università degli Studi di Messina , Messina , Italy.

Roberta Granese (R)

a Dipartimento di Patologia Umana dell'Adulto e dell'Età Evolutiva "G. Barresi" , Università degli Studi di Messina , Messina , Italy.

Silvia Corrado (S)

a Dipartimento di Patologia Umana dell'Adulto e dell'Età Evolutiva "G. Barresi" , Università degli Studi di Messina , Messina , Italy.

Marina Micali (M)

a Dipartimento di Patologia Umana dell'Adulto e dell'Età Evolutiva "G. Barresi" , Università degli Studi di Messina , Messina , Italy.

Angelo Santamaria (A)

a Dipartimento di Patologia Umana dell'Adulto e dell'Età Evolutiva "G. Barresi" , Università degli Studi di Messina , Messina , Italy.

Rosario D'Anna (R)

a Dipartimento di Patologia Umana dell'Adulto e dell'Età Evolutiva "G. Barresi" , Università degli Studi di Messina , Messina , Italy.

Antonino Di Benedetto (A)

b Dipartimento di Medicina Clinica e Sperimentale , Università degli Studi di Messina , Messina , Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH